Skip to content [s] Site map [3] Home [1]
Graphic text

Cancer Research and Foundation News

Targeted Therapies Offer Treatment Options for Advanced Kidney Cancer

January 24, 2012

For decades, oncologists had little reason to be optimistic about treating patients with advanced kidney cancer. But over the past 15 years, important discoveries have produced targeted therapies to treat cancer that has spread beyond the kidney (metastatic disease) and offer new directions for developing even more effective treatments.

Melanoma: New Findings on Drugs that Affect Cancer Growth

January 18, 2012

Roughly one-quarter of patients who take Zelboraf for melanoma develop a troublesome side effect: secondary skin cancers called squamous cell carcinomas. A new study identifies the specific genetic mechanism that causes this side effect, suggesting a possible new treatment regimen.

Robot Prostatectomy: Results Don't Support the Hype

January 6, 2012

Older men considering robotic surgery for prostate cancer shouldn’t trust the rosy ads promoting the expensive technology over low-tech surgery. That’s according to a new survey that found complaints about sexual problems and urinary incontinence were equally common after the two procedures.

Share this Page

Stay Connected

Button Button Button Button

Get Hope!

Sign up for our newsletter and updates.

CHRISTUS Stehlin Foundation for Cancer Research

10301 Stella Link Road, Suite A
Houston, Texas 77025-5447

Affiliates and Resources

Logo Logo Logo Logo Logo